Skip to main content
Figure 2 | BMC Psychiatry

Figure 2

From: Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate

Figure 2

Treatment-emergent adverse events in ≥5% of patients in any BMI-based group from TR baseline to OLE endpoint. Underweight <19 kg/m2 (n = 29) ∆ Normal-weight 19- < 25 kg/m2 (n = 229) □ Overweight 25- < 30 kg/m2 (n = 232) Obese ≥30 kg/m2 (n = 154) Overall (n = 644). BMI- body mass index; TR- transition; OLE- open-label extension.

Back to article page